Plasma Transthyretin as a Biomarker of Lean Body Mass and Catabolic States

• Published in: Advances in nutrition (Bethesda, Md.) Md.), 2015-09, Vol.6 (5), p.572-580
• Main Authors: Ingenbleek, Yves, Bernstein, Larry H
• Format: Article
• Language: English
• Subjects: Biomarkers - blood; Body Mass Index; Down-Regulation; endocrine implications; Humans; inflammation; lean body mass; malnutrition; Prealbumin - metabolism; Retinol-Binding Proteins, Plasma - metabolism; Reviews; Stress, Physiological - drug effects; transthyretin
• ISSN: 2161-8313; 2156-5376; 2156-5376
• DOI: 10.3945/an.115.008508

Plasma transthyretin (TTR) is a plasma protein secreted by the liver that circulates bound to retinol-binding protein 4 (RBP4) and its retinol ligand. TTR is the sole plasma protein that reveals from birth to old age evolutionary patterns that are closely superimposable to those of lean body mass (LBM) and thus works as the best surrogate analyte of LBM. Any alteration in energy-to-protein balance impairs the accretion of LBM reserves and causes early depression of TTR production. In acute inflammatory states, cytokines induce urinary leakage of nitrogenous catabolites, deplete LBM stores, and cause an abrupt decrease in TTR and RBP4 concentrations. As a result, thyroxine and retinol ligands are released in free form, creating a second frontline that strengthens that primarily initiated by cytokines. Malnutrition and inflammation thus keep in check TTR and RBP4 secretion by using distinct and unrelated physiologic pathways, but they operate in concert to downregulate LBM stores. The biomarker complex integrates these opposite mechanisms at any time and thereby constitutes an ideally suited tool to determine residual LBM resources still available for metabolic responses, hence predicting outcomes of the most interwoven disease conditions.